Effective suppression of testosterone: the best castration therapy for hormone-sensitive prostate cancer?

Androgen suppression strategy has become the key treatment of advanced prostate cancer. Historically, testosterone level below 1.73 nmol/l (50 ng/dl) was regarded as the castrate level. The current data shows that in an attempt to improve the therapeutic outcome, the new target for chemical castrati...

Celý popis

Podrobná bibliografie

Hlavní autoři:	A. A. Gritskevich, S. V. Mishugin, A. A. Teplov, V. L. Medvedev, I. G. Rusakov
Médium:	Artigo
Jazyk:	Russo
Vydáno:	Remedium Group LLC 2015-12-01
Edice:	Медицинский совет
Témata:	рак предстательной железы аналоги лютеинизирующего гормона рилизинг-гормон трипторелин тестостерон prostate cancer analogs of luteinizing hormone releasing hormone triptorelin testosterone
On-line přístup:	https://www.med-sovet.pro/jour/article/view/225
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!